Naomi Dempsey

456 total citations
15 papers, 157 citations indexed

About

Naomi Dempsey is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Naomi Dempsey has authored 15 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Naomi Dempsey's work include Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (5 papers) and Advanced Breast Cancer Therapies (3 papers). Naomi Dempsey is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (5 papers) and Advanced Breast Cancer Therapies (3 papers). Naomi Dempsey collaborates with scholars based in United States, India and Jordan. Naomi Dempsey's co-authors include Nitika Dabas, Nanette H. Bishopric, Amanda Rosenthal, Marc E. Lippman, Reshma Mahtani, Vaishali Sanchorawala, James E. Hoffman, Manmeet S. Ahluwalia, Saya Jacob and Sana Al‐Sukhun and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Naomi Dempsey

14 papers receiving 155 citations

Peers

Naomi Dempsey
Merna Armanious United States
Douglas Leedy United States
Agnès Ducoulombier France
Wafaa Elatre United States
Gagan Sahni United States
Nick Pavlakis Australia
Xiaoping Lin China
José María Serrano Antolín Spain
Luc Vittori United States
Merna Armanious United States
Naomi Dempsey
Citations per year, relative to Naomi Dempsey Naomi Dempsey (= 1×) peers Merna Armanious

Countries citing papers authored by Naomi Dempsey

Since Specialization
Citations

This map shows the geographic impact of Naomi Dempsey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Dempsey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Dempsey more than expected).

Fields of papers citing papers by Naomi Dempsey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Dempsey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Dempsey. The network helps show where Naomi Dempsey may publish in the future.

Co-authorship network of co-authors of Naomi Dempsey

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Dempsey. A scholar is included among the top collaborators of Naomi Dempsey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Dempsey. Naomi Dempsey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Dempsey, Naomi, Christine L. Moe, Laura A. Huppert, et al.. (2025). Treatment rechallenge after trastuzumab-deruxtecan–related interstitial lung disease: A multi-institution cohort study.. Journal of Clinical Oncology. 43(16_suppl). 1015–1015. 4 indexed citations
2.
3.
Huppert, Laura A., Reshma Mahtani, Naomi Dempsey, et al.. (2024). Abstract PO4-12-06: Interstitial Lung Disease (ILD) in Sequential Antibody Drug Conjugate (ADC) use in patients with Metastatic Breast Cancer (MBC): A Multi-Institutional experience. Cancer Research. 84(9_Supplement). PO4–12. 1 indexed citations
4.
Dempsey, Naomi, Priya Bhatt, Courtney Lewis, et al.. (2024). Co-occurrence of ESR1 and PIK3CA mutations in HR+/HER2- metastatic breast cancer: Incidence and outcomes with targeted therapy.. Journal of Clinical Oncology. 42(16_suppl). e13097–e13097. 3 indexed citations
5.
6.
Dempsey, Naomi, et al.. (2023). Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?. Current Treatment Options in Oncology. 24(9). 1120–1137. 9 indexed citations
7.
8.
Agarwal, Mohit, Naomi Dempsey, Michael J. Pishvaian, et al.. (2022). Viewing education differently: A novel educational approach using virtual tumor board cases.. Journal of Clinical Oncology. 40(4_suppl). 653–653. 1 indexed citations
9.
Dempsey, Naomi, Mohit Agarwal, James R. Broughman, et al.. (2022). Raising the level of cancer care: Feasibility and reported benefit of a virtual tumor board.. Journal of Clinical Oncology. 40(16_suppl). e18595–e18595.
10.
Dempsey, Naomi, et al.. (2021). Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies. Breast Cancer Research and Treatment. 188(1). 21–36. 91 indexed citations
11.
Gawri, Kunal, et al.. (2021). P01.09 Improved Outcomes With Ramucirumab & Docetaxel in Metastatic Non-Small Cell Lung Cancer After Failure of Immunotherapy. Journal of Thoracic Oncology. 16(3). S239–S240. 3 indexed citations
12.
Auclin, Édouard, Naomi Dempsey, Margarita Majem, et al.. (2021). 1172MO Durvalumab consolidation in patients with stage III non-resecable NSCLC with driver genomic alterations. Annals of Oncology. 32. S940–S941. 3 indexed citations
13.
Hoffman, James E., Naomi Dempsey, & Vaishali Sanchorawala. (2020). Systemic Amyloidosis Caused by Monoclonal Immunoglobulins. Hematology/Oncology Clinics of North America. 34(6). 1099–1113. 9 indexed citations
14.
Dempsey, Naomi, et al.. (2020). Resource-Stratified Guideline-Based Cancer Care Should Be a Priority: Historical Context and Examples of Success. American Society of Clinical Oncology Educational Book. 40(40). 217–226. 6 indexed citations
15.
Dempsey, Naomi, et al.. (2018). Thyroid Storm Triggered by Strangulation in a Patient with Undiagnosed Graves’ Disease. Case Reports in Endocrinology. 2018. 1–3. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Merna Armanious Breakdown of academic impact, for papers by Douglas Leedy Breakdown of academic impact, for papers by Agnès Ducoulombier Breakdown of academic impact, for papers by Wafaa Elatre Breakdown of academic impact, for papers by Gagan Sahni Breakdown of academic impact, for papers by Nick Pavlakis Breakdown of academic impact, for papers by Xiaoping Lin Breakdown of academic impact, for papers by José María Serrano Antolín Breakdown of academic impact, for papers by Luc Vittori
Rankless by CCL
2026